| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 11,870 options to buy
@ $3.85, valued at
$45.7k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 63,060 options to buy
@ $3.18, valued at
$200.5k
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2020 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 83,000 options to buy
@ $1.39, valued at
$115.4k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2019 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Unknown transaction of 2,090 shares
@ $75, valued at
$156.8k
Disposed/sold 4,052 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $26.36, valued at
$659k
Disposed/sold 10,000 options to buy
@ $60.77, valued at
$607.7k
Disposed/sold 12,000 options to buy
@ $47.27, valued at
$567.2k
Disposed/sold 12,000 options to buy
@ $149.22, valued at
$1.8M
Disposed/sold 7,209 options to buy
@ $46.89, valued at
$338k
|
|
| 06/05/2018 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 1,631 shares
@ $0
Granted 7,209 options to buy
@ $46.89, valued at
$338k
Granted 4,052 restricted stock units
@ $0 |
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2017 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 459 shares
@ $0
Granted 12,000 options to buy
@ $149.22, valued at
$1.8M
|
|
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on TESARO, Inc. |
| 12/02/2013 |
3
| COLLIER EARL M JR (Director) has filed a Form 3 on CAPRICOR THERAPEUTICS, INC. |
| 02/12/2010 |
5
| COLLIER EARL M JR (Executive Vice President) has filed a Form 5 on GENZYME CORP |
| 07/31/2009 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on DECODE GENETICS INC |
| 05/27/2009 |
4
| COLLIER EARL M JR (Executive Vice President) has filed a Form 4 on GENZYME CORP |
| 05/26/2009 |
4
| COLLIER EARL M JR (Executive Vice President) has filed a Form 4 on GENZYME CORP |
| 02/12/2009 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |